Metraipolis › archive › dc_42f65989bc4e

Charting the research frontier for viral infections, immunomodulation, and dementia: a perspective on synaptic biomarkers as essential clinical trial endpoints — Europe PMC PMID:41561087

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41561087
DOI: 10.3389/fcimb.2025.1701760
License (as archived): solo-consultazione
Archived: 2026-11-07T01:53:22.461Z
SHA-256 of the archived text: 16017389c990fceabcfebf0d060298c9bde62fa57dd84bc77de779c7245502d1
Stable URL of this page: https://metraipolis.com/documento/dc_42f65989bc4e

How to cite

Charting the research frontier for viral infections, immunomodulation, and dementia: a perspective on synaptic biomarkers as essential clinical trial endpoints — Europe PMC PMID:41561087 — Europe PMC (en), https://europepmc.org/article/MED/41561087 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_42f65989bc4e (Metraipolis archive dc_42f65989bc4e, sha256 16017389c990fceabcfebf0d060298c9bde62fa57dd84bc77de779c7245502d1)

BibTeX

@misc{dc42f65989bc4e,
  title = {Charting the research frontier for viral infections, immunomodulation, and dementia: a perspective on synaptic biomarkers as essential clinical trial endpoints — Europe PMC PMID:41561087},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41561087},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_42f65989bc4e; sha256 16017389c990fceabcfebf0d060298c9bde62fa57dd84bc77de779c7245502d1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41561087. Agents can read the archived copy with the MCP tool read_document.